SymBio Pharmaceuticals Limited (4582.T) JPX
Currency In JPY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In JPY
| Market Cap | 4.52B |
| Enterprise Value | 3.62B |
| P/E Ratio | -0.65 |
| PEG Ratio | 0.55 |
| Price/Sales Ratio | 3.17 |
| Price/Book Ratio | -8.51 |
| Enterprise/Revenue | 3.04 |
| Enterprise/EBITDA | -0.57 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -5.33 |
| Operating Margin | -5.24 |
| Return On Assets | -3.16 |
| Return On Equity | -9.37 |
| Revenue | 1.31B |
| Revenue/Share | 14.81 |
| Gross Profit | 947.34M |
| EBITDA | -4.6B |
| Net Income | -4.78B |
| Diluted EPS | -95.12 |
| Total Cash | 977.18M |
| Total Cash/Share | 12.8 |
| Total Debt | 832.5M |
| Total Debt/Equity | -1.43 |
| Current Ratio | 0.75 |
| Book Value Per Share | -7.63 |
| 52-Week Change | -56.95 |
| 52-Week High | 229 |
| 52-Week Low | 64 |
| Moving Average 50 Days | 69.78 |
| Moving Average 200 Days | 92.35 |
| Average Volume | 789,522 |
| Shares Outstanding | 55.12M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:4 |
| Last Split Date | June 26, 2019 |